Share Price and Basic Stock Data
Last Updated: February 24, 2026, 3:08 pm
| PEG Ratio | -6.43 |
|---|
📊 Last updated
6d ago
Feb 18, 2026
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Jocil Ltd, operating in the chemicals sector, reported a market capitalization of ₹118 Cr and a current price of ₹133 per share. The company has shown fluctuating revenue trends over the past quarters. Sales stood at ₹192.81 Cr in December 2022, rising to ₹200.10 Cr in March 2023, before declining to ₹180.13 Cr in June 2023. The revenue rebounded to ₹218.38 Cr in September 2023 but fell again to ₹172.37 Cr in December 2023. For the trailing twelve months (TTM) ending in March 2025, sales recorded ₹914 Cr, reflecting an annual increase from ₹919 Cr in March 2023. The sales trajectory exhibits volatility, which could impact investor sentiment and long-term growth potential. The company’s revenue per share was ₹974.53 for March 2025, demonstrating a solid operational scale despite the revenue fluctuations. Jocil’s ability to stabilize and grow its top line amidst market challenges will be critical for its future performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 214 Cr. | 135 | 437/131 | 233 | 392 | 0.07 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,293 Cr. | 9,199 | 14,250/7,772 | 49.3 | 1,272 | 0.08 % | 21.2 % | 15.8 % | 10.0 |
| Crestchem Ltd | 28.2 Cr. | 93.9 | 258/73.0 | 12.7 | 26.9 | 1.06 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 148 Cr. | 185 | 435/180 | 22.0 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 3,938.93 Cr | 1,484.23 | 163.89 | 340.12 | 0.45% | 14.61% | 10.60% | 7.56 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 192.81 | 200.10 | 180.13 | 218.38 | 172.37 | 182.32 | 237.70 | 229.74 | 219.95 | 178.15 | 269.94 | 245.78 | 262.72 |
| Expenses | 188.58 | 195.48 | 177.86 | 215.83 | 175.25 | 179.15 | 234.34 | 227.08 | 222.06 | 176.76 | 266.18 | 242.15 | 259.30 |
| Operating Profit | 4.23 | 4.62 | 2.27 | 2.55 | -2.88 | 3.17 | 3.36 | 2.66 | -2.11 | 1.39 | 3.76 | 3.63 | 3.42 |
| OPM % | 2.19% | 2.31% | 1.26% | 1.17% | -1.67% | 1.74% | 1.41% | 1.16% | -0.96% | 0.78% | 1.39% | 1.48% | 1.30% |
| Other Income | 0.54 | 0.69 | 0.91 | 1.40 | 0.56 | 1.10 | 0.77 | 0.40 | 0.10 | 0.68 | 0.49 | 0.31 | 0.14 |
| Interest | 0.24 | 0.18 | 0.01 | 0.00 | 0.27 | 0.05 | 0.00 | 0.10 | 0.07 | 0.06 | 0.06 | 0.19 | 0.05 |
| Depreciation | 1.55 | 1.56 | 1.38 | 1.48 | 1.63 | 1.62 | 1.39 | 1.42 | 1.43 | 1.42 | 1.22 | 1.25 | 1.39 |
| Profit before tax | 2.98 | 3.57 | 1.79 | 2.47 | -4.22 | 2.60 | 2.74 | 1.54 | -3.51 | 0.59 | 2.97 | 2.50 | 2.12 |
| Tax % | 24.83% | 12.32% | 25.14% | 25.51% | -25.12% | 35.00% | 25.18% | 25.32% | -25.36% | 22.03% | 25.25% | 25.20% | 25.00% |
| Net Profit | 2.23 | 3.13 | 1.34 | 1.85 | -3.16 | 1.69 | 2.05 | 1.15 | -2.63 | 0.45 | 2.22 | 1.87 | 1.58 |
| EPS in Rs | 2.51 | 3.52 | 1.51 | 2.08 | -3.56 | 1.90 | 2.31 | 1.29 | -2.96 | 0.51 | 2.50 | 2.11 | 1.78 |
Last Updated: February 5, 2026, 9:38 am
Below is a detailed analysis of the quarterly data for Jocil Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 262.72 Cr.. The value appears strong and on an upward trend. It has increased from 245.78 Cr. (Sep 2025) to 262.72 Cr., marking an increase of 16.94 Cr..
- For Expenses, as of Dec 2025, the value is 259.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 242.15 Cr. (Sep 2025) to 259.30 Cr., marking an increase of 17.15 Cr..
- For Operating Profit, as of Dec 2025, the value is 3.42 Cr.. The value appears to be declining and may need further review. It has decreased from 3.63 Cr. (Sep 2025) to 3.42 Cr., marking a decrease of 0.21 Cr..
- For OPM %, as of Dec 2025, the value is 1.30%. The value appears to be declining and may need further review. It has decreased from 1.48% (Sep 2025) to 1.30%, marking a decrease of 0.18%.
- For Other Income, as of Dec 2025, the value is 0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 0.31 Cr. (Sep 2025) to 0.14 Cr., marking a decrease of 0.17 Cr..
- For Interest, as of Dec 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.19 Cr. (Sep 2025) to 0.05 Cr., marking a decrease of 0.14 Cr..
- For Depreciation, as of Dec 2025, the value is 1.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.25 Cr. (Sep 2025) to 1.39 Cr., marking an increase of 0.14 Cr..
- For Profit before tax, as of Dec 2025, the value is 2.12 Cr.. The value appears to be declining and may need further review. It has decreased from 2.50 Cr. (Sep 2025) to 2.12 Cr., marking a decrease of 0.38 Cr..
- For Tax %, as of Dec 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.20% (Sep 2025) to 25.00%, marking a decrease of 0.20%.
- For Net Profit, as of Dec 2025, the value is 1.58 Cr.. The value appears to be declining and may need further review. It has decreased from 1.87 Cr. (Sep 2025) to 1.58 Cr., marking a decrease of 0.29 Cr..
- For EPS in Rs, as of Dec 2025, the value is 1.78. The value appears to be declining and may need further review. It has decreased from 2.11 (Sep 2025) to 1.78, marking a decrease of 0.33.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 24, 2026, 4:46 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 375 | 331 | 393 | 376 | 341 | 402 | 446 | 565 | 754 | 919 | 753 | 866 | 957 |
| Expenses | 349 | 305 | 361 | 360 | 331 | 396 | 427 | 544 | 738 | 902 | 748 | 860 | 944 |
| Operating Profit | 26 | 25 | 32 | 16 | 11 | 7 | 19 | 21 | 15 | 18 | 5 | 5 | 12 |
| OPM % | 7% | 8% | 8% | 4% | 3% | 2% | 4% | 4% | 2% | 2% | 1% | 1% | 1% |
| Other Income | 2 | 2 | 5 | 3 | 2 | 2 | 6 | 1 | 1 | 2 | 4 | 2 | 2 |
| Interest | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 10 | 7 | 8 | 7 | 7 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 5 |
| Profit before tax | 16 | 20 | 27 | 10 | 5 | 1 | 18 | 15 | 10 | 13 | 3 | 1 | 8 |
| Tax % | 30% | 33% | 34% | 19% | 17% | -152% | 29% | 12% | 26% | 22% | 35% | 24% | |
| Net Profit | 11 | 13 | 18 | 8 | 4 | 3 | 12 | 14 | 7 | 10 | 2 | 1 | 6 |
| EPS in Rs | 12.76 | 14.76 | 20.37 | 9.24 | 4.62 | 3.57 | 14.06 | 15.32 | 8.03 | 11.26 | 1.95 | 1.15 | 6.90 |
| Dividend Payout % | 39% | 41% | 34% | 32% | 43% | 28% | 21% | 20% | 25% | 22% | 77% | 44% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 18.18% | 38.46% | -55.56% | -50.00% | -25.00% | 300.00% | 16.67% | -50.00% | 42.86% | -80.00% | -50.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 20.28% | -94.02% | 5.56% | 25.00% | 325.00% | -283.33% | -66.67% | 92.86% | -122.86% | 30.00% |
Jocil Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 5% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -23% |
| 5 Years: | -40% |
| 3 Years: | -48% |
| TTM: | -51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -3% |
| 3 Years: | -8% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 8:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:29 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 133 | 139 | 150 | 159 | 163 | 165 | 172 | 187 | 195 | 198 | 202 | 197 | 201 |
| Borrowings | 12 | 11 | 9 | 28 | 7 | 8 | 8 | 2 | 4 | 2 | 6 | 0 | 5 |
| Other Liabilities | 89 | 41 | 40 | 54 | 33 | 30 | 51 | 54 | 49 | 46 | 62 | 82 | 74 |
| Total Liabilities | 243 | 200 | 208 | 251 | 212 | 212 | 240 | 252 | 257 | 254 | 279 | 288 | 290 |
| Fixed Assets | 74 | 67 | 63 | 59 | 54 | 50 | 48 | 48 | 47 | 44 | 41 | 37 | 35 |
| CWIP | 0 | 1 | 1 | 2 | 1 | 4 | 5 | 6 | 3 | 0 | 1 | 8 | 9 |
| Investments | 1 | 1 | 1 | 3 | 16 | 9 | 2 | 20 | 9 | 35 | 37 | 30 | 14 |
| Other Assets | 168 | 130 | 143 | 187 | 141 | 150 | 185 | 178 | 198 | 175 | 200 | 212 | 232 |
| Total Assets | 243 | 200 | 208 | 251 | 212 | 212 | 240 | 252 | 257 | 254 | 279 | 288 | 290 |
Below is a detailed analysis of the balance sheet data for Jocil Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
- For Reserves, as of Sep 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 197.00 Cr. (Mar 2025) to 201.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 74.00 Cr.. The value appears to be improving (decreasing). It has decreased from 82.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 8.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 290.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 288.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 2.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 35.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 16.00 Cr..
- For Other Assets, as of Sep 2025, the value is 232.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2025) to 232.00 Cr., marking an increase of 20.00 Cr..
- For Total Assets, as of Sep 2025, the value is 290.00 Cr.. The value appears strong and on an upward trend. It has increased from 288.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 2.00 Cr..
Notably, the Reserves (201.00 Cr.) exceed the Borrowings (5.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 14.00 | 14.00 | 23.00 | -12.00 | 4.00 | -1.00 | 11.00 | 19.00 | 11.00 | 16.00 | -1.00 | 5.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 53 | 57 | 88 | 53 | 52 | 66 | 55 | 36 | 29 | 32 | 21 |
| Inventory Days | 84 | 89 | 75 | 73 | 81 | 71 | 85 | 66 | 58 | 66 | ||
| Days Payable | 28 | 16 | 21 | 43 | 20 | 15 | 38 | 29 | 29 | 33 | ||
| Cash Conversion Cycle | 100 | 126 | 111 | 119 | 114 | 108 | 114 | 91 | 36 | 29 | 61 | 54 |
| Working Capital Days | 66 | 84 | 88 | 92 | 94 | 89 | 87 | 74 | 69 | 49 | 52 | 45 |
| ROCE % | 11% | 13% | 17% | 7% | 3% | 1% | 10% | 9% | 5% | 7% | 1% | 1% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| Diluted EPS (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| Cash EPS (Rs.) | 7.53 | 8.81 | 18.25 | 15.71 | 21.64 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 232.03 | 237.10 | 232.39 | 229.29 | 220.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 232.03 | 237.10 | 232.39 | 229.29 | 220.80 |
| Dividend / Share (Rs.) | 0.50 | 1.50 | 2.50 | 2.00 | 3.00 |
| Revenue From Operations / Share (Rs.) | 974.53 | 848.04 | 1035.04 | 848.48 | 636.56 |
| PBDIT / Share (Rs.) | 8.15 | 10.22 | 22.62 | 18.66 | 24.69 |
| PBIT / Share (Rs.) | 1.77 | 3.35 | 15.63 | 10.98 | 18.37 |
| PBT / Share (Rs.) | 1.51 | 2.98 | 14.35 | 10.78 | 17.37 |
| Net Profit / Share (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| PBDIT Margin (%) | 0.83 | 1.20 | 2.18 | 2.19 | 3.87 |
| PBIT Margin (%) | 0.18 | 0.39 | 1.50 | 1.29 | 2.88 |
| PBT Margin (%) | 0.15 | 0.35 | 1.38 | 1.27 | 2.72 |
| Net Profit Margin (%) | 0.11 | 0.22 | 1.08 | 0.94 | 2.40 |
| Return on Networth / Equity (%) | 0.49 | 0.82 | 4.84 | 3.49 | 6.93 |
| Return on Capital Employeed (%) | 0.75 | 1.39 | 6.60 | 4.69 | 8.12 |
| Return On Assets (%) | 0.35 | 0.61 | 3.94 | 2.77 | 5.39 |
| Total Debt / Equity (X) | 0.00 | 0.02 | 0.01 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | 3.06 | 2.83 | 3.60 | 2.96 | 2.30 |
| Current Ratio (X) | 2.99 | 3.48 | 4.64 | 3.93 | 3.67 |
| Quick Ratio (X) | 1.35 | 2.02 | 2.74 | 1.76 | 2.16 |
| Inventory Turnover Ratio (X) | 7.71 | 6.80 | 7.74 | 6.93 | 5.72 |
| Dividend Payout Ratio (NP) (%) | 130.60 | 128.54 | 17.77 | 37.38 | 19.57 |
| Dividend Payout Ratio (CP) (%) | 19.91 | 28.35 | 10.96 | 19.10 | 13.86 |
| Earning Retention Ratio (%) | -30.60 | -28.54 | 82.23 | 62.62 | 80.43 |
| Cash Earning Retention Ratio (%) | 80.09 | 71.65 | 89.04 | 80.90 | 86.14 |
| Interest Coverage Ratio (X) | 31.18 | 27.47 | 17.68 | 95.69 | 24.67 |
| Interest Coverage Ratio (Post Tax) (X) | 5.39 | 6.23 | 9.80 | 42.15 | 16.31 |
| Enterprise Value (Cr.) | 97.29 | 129.34 | 129.51 | 172.39 | 121.36 |
| EV / Net Operating Revenue (X) | 0.11 | 0.17 | 0.14 | 0.22 | 0.21 |
| EV / EBITDA (X) | 13.43 | 14.25 | 6.45 | 10.40 | 5.53 |
| MarketCap / Net Operating Revenue (X) | 0.14 | 0.19 | 0.14 | 0.22 | 0.22 |
| Retention Ratios (%) | -30.60 | -28.54 | 82.22 | 62.61 | 80.42 |
| Price / BV (X) | 0.59 | 0.71 | 0.65 | 0.84 | 0.65 |
| Price / Net Operating Revenue (X) | 0.14 | 0.19 | 0.14 | 0.22 | 0.22 |
| EarningsYield | 0.01 | 0.01 | 0.07 | 0.04 | 0.10 |
After reviewing the key financial ratios for Jocil Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For Cash EPS (Rs.), as of Mar 25, the value is 7.53. This value is within the healthy range. It has decreased from 8.81 (Mar 24) to 7.53, marking a decrease of 1.28.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.03. It has decreased from 237.10 (Mar 24) to 232.03, marking a decrease of 5.07.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.03. It has decreased from 237.10 (Mar 24) to 232.03, marking a decrease of 5.07.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.50 (Mar 24) to 0.50, marking a decrease of 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 974.53. It has increased from 848.04 (Mar 24) to 974.53, marking an increase of 126.49.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has decreased from 10.22 (Mar 24) to 8.15, marking a decrease of 2.07.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.77. This value is within the healthy range. It has decreased from 3.35 (Mar 24) to 1.77, marking a decrease of 1.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.51. This value is within the healthy range. It has decreased from 2.98 (Mar 24) to 1.51, marking a decrease of 1.47.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 2. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For PBDIT Margin (%), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 10. It has decreased from 1.20 (Mar 24) to 0.83, marking a decrease of 0.37.
- For PBIT Margin (%), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 10. It has decreased from 0.39 (Mar 24) to 0.18, marking a decrease of 0.21.
- For PBT Margin (%), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 10. It has decreased from 0.35 (Mar 24) to 0.15, marking a decrease of 0.20.
- For Net Profit Margin (%), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.22 (Mar 24) to 0.11, marking a decrease of 0.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 15. It has decreased from 0.82 (Mar 24) to 0.49, marking a decrease of 0.33.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 10. It has decreased from 1.39 (Mar 24) to 0.75, marking a decrease of 0.64.
- For Return On Assets (%), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 5. It has decreased from 0.61 (Mar 24) to 0.35, marking a decrease of 0.26.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 3.06. It has increased from 2.83 (Mar 24) to 3.06, marking an increase of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 2.99. This value is within the healthy range. It has decreased from 3.48 (Mar 24) to 2.99, marking a decrease of 0.49.
- For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.02 (Mar 24) to 1.35, marking a decrease of 0.67.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 6.80 (Mar 24) to 7.71, marking an increase of 0.91.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 130.60. This value exceeds the healthy maximum of 50. It has increased from 128.54 (Mar 24) to 130.60, marking an increase of 2.06.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.91. This value is below the healthy minimum of 20. It has decreased from 28.35 (Mar 24) to 19.91, marking a decrease of 8.44.
- For Earning Retention Ratio (%), as of Mar 25, the value is -30.60. This value is below the healthy minimum of 40. It has decreased from -28.54 (Mar 24) to -30.60, marking a decrease of 2.06.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.09. This value exceeds the healthy maximum of 70. It has increased from 71.65 (Mar 24) to 80.09, marking an increase of 8.44.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 31.18. This value is within the healthy range. It has increased from 27.47 (Mar 24) to 31.18, marking an increase of 3.71.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.39. This value is within the healthy range. It has decreased from 6.23 (Mar 24) to 5.39, marking a decrease of 0.84.
- For Enterprise Value (Cr.), as of Mar 25, the value is 97.29. It has decreased from 129.34 (Mar 24) to 97.29, marking a decrease of 32.05.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 1. It has decreased from 0.17 (Mar 24) to 0.11, marking a decrease of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 13.43. This value is within the healthy range. It has decreased from 14.25 (Mar 24) to 13.43, marking a decrease of 0.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.14, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is -30.60. This value is below the healthy minimum of 30. It has decreased from -28.54 (Mar 24) to -30.60, marking a decrease of 2.06.
- For Price / BV (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.59, marking a decrease of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.14, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Jocil Ltd:
- Net Profit Margin: 0.11%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.75% (Industry Average ROCE: 14.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.49% (Industry Average ROE: 10.6%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.39
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 19.2 (Industry average Stock P/E: 163.89)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.11%
About the Company - Qualitative Analysis
Jocil Ltd. is a Public Limited Listed company incorporated on 20/02/1978 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L28990AP1978PLC002260 and registration number is 002260. Currently company belongs to the Industry of Chemicals - Organic - Others. Company's Total Operating Revenue is Rs. 865.54 Cr. and Equity Capital is Rs. 8.88 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Dokiparru Village, Medikondur Mandal, Guntur District Andhra Pradesh 522438 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. P Narendranath Chowdary | Chairman |
| Mr. J Murali Mohan | Managing Director |
| Mr. Mullapudi Thimmaraja | Director |
| Mr. K Srinivasa Rao | Director |
| Mr. M Mrutyumjaya Prasad | Director |
| Mr. V S Raju | Independent Director |
| Mrs. Bhargavi Vangala | Independent Director |
| Mr. K Rama Seshayya | Independent Director |
| Mr. P A Chowdary | Independent Director |
| Mr. P Kesavulu Reddy | Independent Director |
| Mr. G S V Prasad | Independent Director |
FAQ
What is the intrinsic value of Jocil Ltd?
Jocil Ltd's intrinsic value (as of 25 February 2026) is ₹16.95 which is 87.16% lower the current market price of ₹132.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹117 Cr. market cap, FY2025-2026 high/low of ₹178/121, reserves of ₹201 Cr, and liabilities of ₹290 Cr.
What is the Market Cap of Jocil Ltd?
The Market Cap of Jocil Ltd is 117 Cr..
What is the current Stock Price of Jocil Ltd as on 25 February 2026?
The current stock price of Jocil Ltd as on 25 February 2026 is ₹132.
What is the High / Low of Jocil Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Jocil Ltd stocks is ₹178/121.
What is the Stock P/E of Jocil Ltd?
The Stock P/E of Jocil Ltd is 19.2.
What is the Book Value of Jocil Ltd?
The Book Value of Jocil Ltd is 236.
What is the Dividend Yield of Jocil Ltd?
The Dividend Yield of Jocil Ltd is 0.38 %.
What is the ROCE of Jocil Ltd?
The ROCE of Jocil Ltd is 0.71 %.
What is the ROE of Jocil Ltd?
The ROE of Jocil Ltd is 0.48 %.
What is the Face Value of Jocil Ltd?
The Face Value of Jocil Ltd is 10.0.